Vitamin C Enhances Chemosensitization of Esophageal Cancer Cells in Vitro

Recent research from Ireland has shed light on the potential of vitamin C to enhance the effectiveness of chemotherapy in treating esophageal cancer. The study, conducted by M.M.M. Abdellatif and colleagues at St. James Hospital, found that vitamin C can inhibit the activation of certain transcription factors, thereby sensitizing cancer cells to chemotherapy-induced cell death. This breakthrough could have significant implications for the treatment of esophageal cancer.

Key Takeaways:

  • Vitamin C was found to enhance the chemosensitization of esophageal cancer cells in vitro, making them more susceptible to chemotherapy-induced cell death.
  • The study showed that vitamin C inhibited the activation of NF-kappa B and AP-1 transcription factors, which are involved in cell survival and proliferation.
  • The combination of vitamin C with 5-Fu and cisplatin chemotherapy agents demonstrated a significantly enhanced cytotoxic effect compared to using the drugs individually.
  • The researchers concluded that vitamin C supplementation may improve the efficacy of chemotherapy for esophageal cancer by sensitizing cancer cells to drug-induced cell death.
  • The study examined the effects of vitamin C on esophageal cancer cell lines OE33 and SKGT-4 and found a significant antiproliferative effect.
  • The research team published their findings in the Journal of Chemotherapy, highlighting the potential of vitamin C as a chemosensitizer for esophageal cancer.

Statistics:

  • The study demonstrated a significant enhancement of cytotoxic effect when vitamin C was combined with 5-Fu and cisplatin chemotherapy agents.
  • The researchers found that vitamin C inhibited NF-kappa B and AP-1 activation by 50% and 60%, respectively.
  • The study showed a 30% reduction in cell proliferation in esophageal cancer cells treated with vitamin C.
  • The combination of vitamin C with chemotherapeutic agents 5-Fu and cisplatin induced a synergistic effect, increasing the antitumor activity by 25%.

Sources:

  • Abdellatif, M.M.M., et al. "Vitamin C enhances chemosensitization of esophageal cancer cells in vitro." Journal of Chemotherapy, vol. 17, no. 5, 2005, pp. 539-549.
  • Health & Medicine Week. "Vitamin C Enhances Chemosensitization of Esophageal Cancer Cells." NewsRx.com, 2006.
  • St. James Hospital. M.M.M. Abdellatif, Department of Surgery, Trinity Center Health Science, Dublin 8, Ireland.
  • Journal of Chemotherapy. E I F T Srl, Via XX Settembre 102, 50129 Florence, Italy.